Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Regenfast for Subepithelial Connective Tissue Graft Maturation
NCT07708051Not yet recruiting
- Sponsor
- Universidade de São Paulo
- Start
- Jul 2026
- Primary completion
- Oct 2026
01
Overview
Randomised trial of Regenfast in wound healing (2 arms), sponsored by Universidade de São Paulo. Primary endpoints: Histological Tissue Architecture of the Subepithelial Connective Tissue Graft at 9 weeks, Collagen Density and Fiber Maturation of the Subepithelial Connective Tissue Graft at 9 weeks and 1 more. Planned start Jul 2026; status: not yet recruiting.
02
Drugs
Regenfast
03
Conditions
wound healing
Beyond the preview
Go deeper on NCT07708051.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07708051.